Φορτώνει......
Kallistatin treatment attenuates lethality and organ injury in mouse models of established sepsis
INTRODUCTION: Kallistatin levels in the circulation are reduced in patients with sepsis and liver disease. Transgenic mice expressing kallistatin are resistant to lipopolysaccharide (LPS)-induced mortality. Here, we investigated the effect of kallistatin on survival and organ damage in mouse models...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Crit Care |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
BioMed Central
2015
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4445990/ https://ncbi.nlm.nih.gov/pubmed/25930108 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13054-015-0919-4 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|